BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21978222)

  • 1. Mechanism of membrane interaction and disruption by α-synuclein.
    Reynolds NP; Soragni A; Rabe M; Verdes D; Liverani E; Handschin S; Riek R; Seeger S
    J Am Chem Soc; 2011 Dec; 133(48):19366-75. PubMed ID: 21978222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of alpha-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR.
    Ramakrishnan M; Jensen PH; Marsh D
    Biochemistry; 2006 Mar; 45(10):3386-95. PubMed ID: 16519533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane interaction of α-synuclein in different aggregation states.
    Grey M; Linse S; Nilsson H; Brundin P; Sparr E
    J Parkinsons Dis; 2011; 1(4):359-71. PubMed ID: 23933657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
    van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
    J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane binding of oligomeric alpha-synuclein depends on bilayer charge and packing.
    van Rooijen BD; Claessens MM; Subramaniam V
    FEBS Lett; 2008 Nov; 582(27):3788-92. PubMed ID: 18930058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein insertion into supported lipid bilayers as seen by in situ X-ray reflectivity.
    Hähl H; Möller I; Kiesel I; Campioni S; Riek R; Verdes D; Seeger S
    ACS Chem Neurosci; 2015 Mar; 6(3):374-9. PubMed ID: 25523270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein/lipid coaggregates are formed during α-synuclein-induced disruption of lipid bilayers.
    van Maarschalkerweerd A; Vetri V; Langkilde AE; Foderà V; Vestergaard B
    Biomacromolecules; 2014 Oct; 15(10):3643-54. PubMed ID: 25210839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-triggered membrane interaction of the alpha-synuclein acidic tail.
    Tamamizu-Kato S; Kosaraju MG; Kato H; Raussens V; Ruysschaert JM; Narayanaswami V
    Biochemistry; 2006 Sep; 45(36):10947-56. PubMed ID: 16953580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-bound structure and energetics of alpha-synuclein.
    Mihajlovic M; Lazaridis T
    Proteins; 2008 Feb; 70(3):761-78. PubMed ID: 17729279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observation of multiple intermediates in alpha-synuclein fibril formation by singular value decomposition analysis.
    Kamiyoshihara T; Kojima M; Uéda K; Tashiro M; Shimotakahara S
    Biochem Biophys Res Commun; 2007 Apr; 355(2):398-403. PubMed ID: 17300751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet amyloid polypeptide forms rigid lipid-protein amyloid fibrils on supported phospholipid bilayers.
    Domanov YA; Kinnunen PK
    J Mol Biol; 2008 Feb; 376(1):42-54. PubMed ID: 18155730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy.
    Hoyer W; Cherny D; Subramaniam V; Jovin TM
    J Mol Biol; 2004 Jun; 340(1):127-39. PubMed ID: 15184027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
    Heise H; Celej MS; Becker S; Riedel D; Pelah A; Kumar A; Jovin TM; Baldus M
    J Mol Biol; 2008 Jul; 380(3):444-50. PubMed ID: 18539297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE
    J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity.
    Rekas A; Adda CG; Andrew Aquilina J; Barnham KJ; Sunde M; Galatis D; Williamson NA; Masters CL; Anders RF; Robinson CV; Cappai R; Carver JA
    J Mol Biol; 2004 Jul; 340(5):1167-83. PubMed ID: 15236975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trehalose inhibits fibrillation of A53T mutant alpha-synuclein and disaggregates existing fibrils.
    Yu WB; Jiang T; Lan DM; Lu JH; Yue ZY; Wang J; Zhou P
    Arch Biochem Biophys; 2012 Jul; 523(2):144-50. PubMed ID: 22575388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly.
    Ghee M; Melki R; Michot N; Mallet J
    FEBS J; 2005 Aug; 272(16):4023-33. PubMed ID: 16098186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous IR-Spectroscopic Observation of α-Synuclein, Lipids, and Solvent Reveals an Alternative Membrane-Induced Oligomerization Pathway.
    Fallah MA; Gerding HR; Scheibe C; Drescher M; Karreman C; Schildknecht S; Leist M; Hauser K
    Chembiochem; 2017 Dec; 18(23):2312-2316. PubMed ID: 28980756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.
    Kumar S; Sarkar A; Sundar D
    Biochem Biophys Res Commun; 2009 Sep; 387(2):305-9. PubMed ID: 19580781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raised calcium promotes α-synuclein aggregate formation.
    Nath S; Goodwin J; Engelborghs Y; Pountney DL
    Mol Cell Neurosci; 2011 Feb; 46(2):516-26. PubMed ID: 21145971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.